Search Results - Jerald Radich

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Solving the mystery of myelodysplasia. by Jerald Radich

    Published in PLoS Medicine (2008-02-01)
    Get full text
    Article


  2. 2

    Is DNA a better assay for residual disease in chronic myeloid leukemia? by Jerald Radich

    Published in Haematologica (2018-12-01)
    Get full text
    Article


  3. 3

    MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia by Fekadu Urgessa, Isaac Jenkins, Aster Tsegaye, Helen Nigussie, Teklu Kuru, Amha Gebremedhin, Fozia Abdela, Fisihatsion Tadesse, Jerald Radich

    Published in Scientific Reports (2025-08-01)
    Get full text
    Article


  4. 4

    Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethi... by Fekadu Urgessa, Boki Lengiso, Aster Tsegaye, Amha Gebremedhin, Fozia Abdella, Fisihatsion Tadesse, Jerald Radich, Helen Nigussie, Teklu Kuru Gerbaba

    Published in BMC Cancer (2024-04-01)
    Get full text
    Article


  5. 5

    Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing. by Olga Sala-Torra, Shishir Reddy, Ling-Hong Hung, Lan Beppu, David Wu, Jerald Radich, Ka Yee Yeung, Cecilia C S Yeung

    Published in PLOS Global Public Health (2023-01-01)
    Get full text
    Article


  6. 6

    Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year res... by Jorge E. Cortes, Qian Jiang, Jianxiang Wang, Jianyu Weng, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong-Wook Kim, Jerald Radich, Michael Savona, Patricia Martin-Regueira, Oumar Sy, Giuseppe Saglio

    Published in Haematologica (2024-05-01)
    Get full text
    Article


  7. 7

    Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies by David W. Woolston, Nathan D. Lee, Mazyar Shadman, Elena Latorre-Esteves, Xin Ray Tee, Jeanne Fredrickson, Brendan F. Kohrn, Chaitra Ujjani, Ashley Eckel, Brian Till, Min Fang, Jerald Radich, Ivana Bozic, Rosa Ana Risques, Cecilia C.S. Yeung

    Published in Haematologica (2023-09-01)
    Get full text
    Article


  8. 8

    <i>Erratum</i> to: Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies by David W. Woolston, Nathan D. Lee, Mazyar Shadman, Elena Latorre-Esteves, Xin Ray Tee, Jeanne Fredrickson, Brendan F. Kohrn, Chaitra Ujjani, Ashley Eckel, Brian Till, Min Fang, Jerald Radich, Ivana Bozic, Rosa Ana Risques, Cecilia C.S. Yeung

    Published in Haematologica (2024-07-01)
    Get full text
    Article


  9. 9

    Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized... by Deborah L. White, Jerald Radich, Simona Soverini, Verity A Saunders, Amity K. Frede, Phuong Dang, Daniela Cilloni, Peter Lin, Lidia Mongay, Richard Woodman, Paul Manley, Cassandra Slader, Dong Wook Kim, Fabrizio Pane, Giovanni Martinelli, Giuseppe Saglio, Timothy P. Hughes

    Published in Haematologica (2012-06-01)
    Get full text
    Article


  10. 10

    Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy by Sabrina Angelini, Simona Soverini, Gloria Ravegnini, Matt Barnett, Eleonora Turrini, Mark Thornquist, Fabrizio Pane, Timothy P. Hughes, Deborah L. White, Jerald Radich, Dong Wook Kim, Giuseppe Saglio, Daniela Cilloni, Ilaria Iacobucci, Giovanni Perini, Richard Woodman, Giorgio Cantelli-Forti, Michele Baccarani, Patrizia Hrelia, Giovanni Martinelli

    Published in Haematologica (2013-02-01)
    Get full text
    Article


Search Tools: